Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
AstraZeneca
Medtronic
Farmers Insurance
Cerilliant
Baxter
Accenture

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201688

« Back to Dashboard

NDA 201688 describes TOBI PODHALER, which is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the TOBI PODHALER profile page.

The generic ingredient in TOBI PODHALER is tobramycin. There are eighteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the tobramycin profile page.
Summary for 201688
Tradename:TOBI PODHALER
Applicant:Novartis
Ingredient:tobramycin
Patents:7
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 201688
Ingredient-typeAminoglycosides
Medical Subject Heading (MeSH) Categories for 201688
Suppliers and Packaging for NDA: 201688
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOBI PODHALER tobramycin POWDER;INHALATION 201688 NDA Novartis Pharmaceuticals Corporation 0078-0630 N 0078-0630-20
TOBI PODHALER tobramycin POWDER;INHALATION 201688 NDA Novartis Pharmaceuticals Corporation 0078-0630 N 0078-0630-35

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength28MG
Approval Date:Mar 22, 2013TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Dec 19, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA
Patent:➤ Sign UpPatent Expiration:May 10, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Jan 11, 2024Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Citi
QuintilesIMS
Argus Health
Mallinckrodt
Covington
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.